| Human CD8+ T cell cross-reactivity across influenza A, B and C viruses M Koutsakos, PT Illing, THO Nguyen, NA Mifsud, JC Crawford, S Rizzetto, ... Nature immunology 20 (5), 613-625, 2019 | 203 | 2019 |
| Suboptimal SARS-CoV-2− specific CD8+ T cell response associated with the prominent HLA-A* 02: 01 phenotype JR Habel, THO Nguyen, CE van de Sandt, JA Juno, P Chaurasia, ... Proceedings of the National Academy of Sciences 117 (39), 24384-24391, 2020 | 189 | 2020 |
| Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 134 | 2021 |
| Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 132 | 2021 |
| CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen, LC Rowntree, J Petersen, BY Chua, L Hensen, L Kedzierski, ... Immunity 54 (5), 1066-1082. e5, 2021 | 117 | 2021 |
| Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines BY Chua, M Al Kobaisi, W Zeng, D Mainwaring, DC Jackson Molecular Pharmaceutics 9 (1), 81-90, 2012 | 117 | 2012 |
| Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model PC Proud, D Tsitoura, RJ Watson, BY Chua, MJ Aram, KR Bewley, ... EBioMedicine 63, 2021 | 86 | 2021 |
| Recalling the future: immunological memory toward unpredictable influenza viruses M Auladell, X Jia, L Hensen, B Chua, A Fox, THO Nguyen, PC Doherty, ... Frontiers in immunology 10, 454404, 2019 | 85 | 2019 |
| A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals EJ Gowans, S Roberts, K Jones, I Dinatale, PA Latour, B Chua, ... Journal of hepatology 53 (4), 599-607, 2010 | 78 | 2010 |
| A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection BY Chua, EM Eriksson, LE Brown, W Zeng, EJ Gowans, J Torresi, ... Vaccine 26 (37), 4866-4875, 2008 | 64 | 2008 |
| Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups BY Chua, W Zeng, YF Lau, DC Jackson Vaccine 25 (1), 92-101, 2007 | 64 | 2007 |
| Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys W Zeng, E Eriksson, B Chua, L Grollo, DC Jackson Amino Acids 39, 471-480, 2010 | 57 | 2010 |
| Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses BY Chua, D Johnson, A Tan, L Earnest-Silveira, T Sekiya, R Chin, ... Public Library of Science 7 (10), e47492, 2012 | 55 | 2012 |
| An insect antibacterial peptide-based drug delivery system L Otvos, M Cudic, BY Chua, G Deliyannis, DC Jackson Molecular pharmaceutics 1 (3), 220-232, 2004 | 55 | 2004 |
| Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2 BY Chua, D Pejoski, SJ Turner, W Zeng, DC Jackson The Journal of Immunology 187 (4), 1692-1701, 2011 | 48 | 2011 |
| The use of a TLR2 agonist‐based adjuvant for enhancing effector and memory CD8 T‐cell responses BY Chua, MR Olson, S Bedoui, T Sekiya, CY Wong, SJ Turner, ... Immunology and cell biology 92 (4), 377-383, 2014 | 44 | 2014 |
| Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus BY Chua, A Healy, PU Cameron, O Stock, M Rizkalla, W Zeng, J Torresi, ... Immunology and cell biology 81 (1), 67-72, 2003 | 42 | 2003 |
| Inactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-term adaptive immunity BY Chua, CY Wong, EJ Mifsud, KM Edenborough, T Sekiya, ACL Tan, ... MBio 6 (6), 10.1128/mbio. 01024-15, 2015 | 40 | 2015 |
| Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine D Christiansen, L Earnest-Silveira, B Chua, P Meuleman, I Boo, ... Scientific reports 8 (1), 6483, 2018 | 37 | 2018 |
| Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features LC Rowntree, BY Chua, S Nicholson, M Koutsakos, L Hensen, C Douros, ... Clinical & translational immunology 10 (3), e1258, 2021 | 33 | 2021 |
